Design, synthesis and biological evaluation of a new thieno[2,3- d ]pyrimidine-based urea derivative with potential antitumor activity against tamoxifen sensitive and resistant breast cancer cell lines.

MLA

Sharaky, Marwa, et al. “Design, Synthesis and Biological Evaluation of a New Thieno[2,3- d ]Pyrimidine-Based Urea Derivative with Potential Antitumor Activity against Tamoxifen Sensitive and Resistant Breast Cancer Cell Lines.” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 35, no. 1, Dec. 2020, pp. 1641–56. EBSCOhost, https://doi.org/10.1080/14756366.2020.1804383.

APA

Sharaky, M., Kamel, M., Aziz, M. A., Omran, M., Rageh, M. M., Abouzid, K. A. M., & Shouman, S. A. (2020). Design, synthesis and biological evaluation of a new thieno[2,3- d ]pyrimidine-based urea derivative with potential antitumor activity against tamoxifen sensitive and resistant breast cancer cell lines. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 1641–1656. https://doi.org/10.1080/14756366.2020.1804383

Chicago

Sharaky, Marwa, Marwa Kamel, Marwa A Aziz, Mervat Omran, Monira M Rageh, Khaled A M Abouzid, and Samia A Shouman. 2020. “Design, Synthesis and Biological Evaluation of a New Thieno[2,3- d ]Pyrimidine-Based Urea Derivative with Potential Antitumor Activity against Tamoxifen Sensitive and Resistant Breast Cancer Cell Lines.” Journal of Enzyme Inhibition and Medicinal Chemistry 35 (1): 1641–56. doi:10.1080/14756366.2020.1804383.